Patent ID: 11939306
Assignee: CURIS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 10:
11. The method of claim 1, wherein the cancer is selected from brain stem glioma, osteosarcoma, bone cancer, prostate cancer, cancer of the small intestine, rectal cancer, cancer of the anal region, melanoma, epithelial cancer, skin cancer, uterine cancer, cancer of the peritoneum, stomach cancer, carcinoma of the fallopian tubes, carcinoma of the endometrium, cancer of the esophagus, gastric carcinoma, prostate adenocarcinoma, colorectal adenocarcinoma, carcinoma of the renal pelvis, hepatocellular cancer, hepatic carcinoma, liver cancer, pancreatic cancer, pancreatic adenocarcinoma, myeloma, multiple myeloma, cancer of the bladder, and bladder carcinoma.